DEXCOM, INC. (DXCM) Capital expenditures 2016–2025
DEXCOM, INC. (DXCM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$363.5MFY2025 · since FY2016: $55.7M → $363.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $363.5M | +1.3% |
| FY2024 | $358.8M | +51.6% |
| FY2023 | $236.6M | -35.1% |
| FY2022 | $364.8M | -6.3% |
| FY2021 | $389.2M | +95.6% |
| FY2020 | $199.0M | +10.6% |
| FY2019 | $180.0M | +168.3% |
| FY2018 | $67.1M | +1.7% |
| FY2017 | $66.0M | +18.5% |
| FY2016 | $55.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice